Literature DB >> 30449527

Management of the Neck in Oral Squamous Cell Carcinoma: Background, Classification, and Current Philosophy.

Payam Afzali1, Brent Benson Ward2.   

Abstract

Nodal metastasis is the single most prognostic determinant in patients with oral squamous cell carcinoma (OSCC). Since its inception more than a century ago, the management of the neck has led to decreased surgical morbidity, with continued preservation of oncologic safety for OSCC. Nodal metastasis is the single most prognostic determinant in patients with OSCC. The decision for the extent of the neck dissection is tailored to tumor-specific characteristics, which dictate the probability and extent of nodal metastasis, including tumor size, location, histopathologic characteristics, and the presence or absence of clinical nodal disease. These factors are tools to aid diagnosticians in their decision making for individual patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Head and neck cancer; Neck dissection; Oral cancer treatment

Mesh:

Year:  2019        PMID: 30449527     DOI: 10.1016/j.coms.2018.09.004

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  3 in total

1.  Epigallocatechin-3-gallate sensitises multidrug-resistant oral carcinoma xenografts to vincristine sulfate.

Authors:  Li Chen; Xianwen Guo; Ye Hu; Li Li; Gang Liang; Guo Zhang
Journal:  FEBS Open Bio       Date:  2020-06-18       Impact factor: 2.693

2.  Lingual Lymph Node Metastasis in cT1-2N0 Tongue Squamous Cell Carcinoma: Is It an Indicator for Elective Neck Dissection.

Authors:  Wenli Yang; Minglei Sun; Qiaoyan Jie; Haixia Zhou; Peng Zhang; Juanfang Zhu
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

3.  Research on neck dissection for oral squamous-cell carcinoma: a bibliometric analysis.

Authors:  Zhou Jiang; Chenzhou Wu; Shoushan Hu; Nailin Liao; Yingzhao Huang; Haoran Ding; Ruohan Li; Yi Li
Journal:  Int J Oral Sci       Date:  2021-04-01       Impact factor: 6.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.